GCG and type 2 diabetes mellitus: Considering the difference between randomized controlled trials (RCT) and real-life clinical practice, we analyzed the determinants of GLP-1 RA-mediated CV protection in a real-world population of patients with type 2 diabetes attending the outpatient clinic of a large university hospital located in the metropolitan area of Milan, Italy.